S&P 500 7,442.02 −3.21%
Nasdaq 24,464.14 −4.94%
S&P/TSX 35,758.16 −1.60%
Apple 348.04 −0.42%
Nvidia 183.60 −8.26%
Microsoft 537.11 −3.36%
Shopify 196.15 −7.79%
Royal Bank 288.00 −1.56%
CAD/USD 0.7146 +0.08%
LIVE · 11:00 ET
Market ClerkRecap
Thu Nov 5 · markets open2 signals today194 insider buys this week · $438.8MCIRO short report next: Nov 15The week ahead
SG
INSIDER · REGN · REGENERON PHARMACEUTICALS, INC. · DIRECTOR

SING GEORGE L

Every open-market transaction filed under this name, Nov 2 to Nov 2.

Filings
9
0 buys · 9 sells
Bought
—
open market, at cost
Sold
$20.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell200$970.18$194K−3.6%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell1,040$967.07$1M−3.3%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell1,522$966.27$1.5M−3.2%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell7,073$965.38$6.8M−3.1%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell2,670$964.57$2.6M−3.1%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell4,338$963.47$4.2M−3.0%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell2,522$962.61$2.4M−2.9%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell540$961.85$519K−2.8%
Nov 2REGNREGENERON PHARMACEUTICALS, INC.DirectorSell1,224$960.57$1.2M−2.7%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.